BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Genetown

  BCC Research Publishes a New Report on Global Markets and Technologies for Endoscopy Devices

  September 3, 2013

   · 

  2 min read
• Deals

  Axxess Pharma, Inc. Announces MOU to Acquire Leading Canadian OTC Healthcare Company

  September 3, 2013

   · 

  3 min read
• Nanomed Line on the Horizon

  September 3, 2013

   · 

  5 min read
• Business

  Selcia Limited and Cantab Pharmaceuticals PLC Announce Drug Discovery Collaboration

  September 3, 2013

   · 

  3 min read
• Drug Development

  Totality of Data From Three Phase III Trials of The Medicines Company’s Intravenous Cangrelor Presented and Published

  September 3, 2013

   · 

  5 min read
• Acacia Pharma Raises $23.5 Million to Advance Clinical Development of Lead Products for Supportive Care

  September 3, 2013

   · 

  4 min read
• Lone Star Bio

  Lab7 Systems Launches BioBuilds, SeqSigma, and DashO3 to Accelerate and Streamline Genomic Data Processing

  September 3, 2013

   · 

  2 min read
• Business

  AmerisourceBergen Corporation Kicks Off 10-Year Distribution Agreement With Walgreens to Supply Pharmaceuticals Across More Than 8,100 Locations

  September 3, 2013

   · 

  1 min read
• Pharm Country

  Struggling Mela Sciences Receives De-Listing Notice From NASDAQ

  September 3, 2013

   · 

  1 min read
• Oramed Pharmaceuticals Inc. Submits Pre-IND Package to FDA for ORMD-0901 (oral exenatide), an Oral GLP-1 Analog for the Treatment of Type 2 Diabetes

  September 3, 2013

   · 

  1 min read